Trends in Cardiovascular Medicine

Journal

Publication Venue For

  • Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD.  33:53-61. 2023
  • Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021.  31:135-140. 2021
  • Lung function and cardiovascular disease: A link.  31:93-98. 2021
  • Editorial Commentary: miRNA a tiny genetic tool: Key to the puzzle of cardiovascular disease.  26:420-422. 2016
  • Angiotensin receptor blockers: Focus on cardiac and renal injury.  26:221-228. 2016
  • RNA-stabilizing proteins as molecular targets in cardiovascular pathologies.  25:676-683. 2015
  • Enhancer-associated long noncoding RNAs: A novel frontier with new perception in cardiac regeneration.  25:603-605. 2015
  • HDAC-dependent ventricular remodeling.  23:229-235. 2013
  • Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb..  20:238-246. 2010
  • The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis.  18:61-66. 2008
  • The role of high-density lipoprotein in inflammation.  15:158-161. 2005
  • Cellular basis of triggered arrhythmias in heart failure.  14:61-66. 2004
  • Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications.  10:246-252. 2000
  • Gender and cardiovascular disease: Recent insights.  7:94-100. 1997
  • Nitric oxide synthases in the cardiovascular system.  3:104-110. 1993

    • International Standard Serial Number (issn)

  • 1050-1738

    • Electronic International Standard Serial Number (eissn)

  • 1873-2615